LXRX
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
Friday, March 28, 2025 1 min read
Key Takeaway: Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
Full Press Release Details
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851.